Implantable device uses ultrasound to improve drug delivery to the brain
By Anne Trafton
Patients with glioblastoma, an aggressive type of brain tumor, usually undergo surgery to remove the tumor. However, it’s difficult for surgeons to remove all of the cancer cells, and the tumor often recurs.
MIT researchers have now designed an implantable drug-delivery device that they hope could help prevent recurrence of glioblastoma.
Their device contains a reservoir that can release drugs over an extended period, along with ultrasound transducers that use sound waves to help drugs spread farther through the brain and bypass the blood-brain barrier.
Such a device could be implanted in the brain during surgery, then gradually release drugs that would help kill the remaining tumor cells. After implantation, a wireless controller can be used to program the exact ultrasound dosages to be delivered, enhancing the reach of the delivered therapy.
“We have 24 transducers in one ultrasound array, which can help a given drug bypass the blood-brain barrier and enhance the drug infusion. The device also gives doctors options in terms of the size, the length, and the number of infusions,” says Canan Dagdeviren, an associate professor of media arts and sciences at MIT and the senior author of the study.
In a paper appearing today in the journal Device, the researchers showed that their ultrasound device allowed molecules to spread further after being released, in tissue models and in a mouse study.
MIT graduate student Sarah Ornellas and Jason Hou PhD ’26 are the lead authors of the study.
In the new study, her lab combined these technologies to create LUCID (Long-term Ultrasound-enhanced Convective Injection Device) — a flexible implant as thin as a sheet of cardstock. A drug-delivery cannula is 3D-printed directly onto an array of 24 miniature ultrasound transducers. These transducers generate ultrasound waves right at the tip of the needle, helping drug molecules to diffuse farther into tissue after they are released.
“Getting a drug into the brain is only part of the challenge. It also needs to spread through the surrounding tissue. We brought a delivery channel and a tiny ultrasound array together in one implant to help molecules reach a larger area, even during slow infusion,” says Hou.